CTOs on the Move


 
Inogen`s mission to improve the quality of life of supplemental oxygen users began in 2001 when Mae, a beloved Grandmother, was prescribed oxygen therapy. Learn more about Mae`s Story here: http://www.inogen.com/about-inogen/meet-mae/. Inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. We estimate that more than 2.5 million patients in the United States and more than 4.5 million patients worldwide use oxygen therapy. Our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.inogen.com
  • 326 Bollay Drive
    Goleta, CA USA 93117
  • Phone: 855.631.2438

Executives

Name Title Contact Details

Similar Companies

Dental Arts Orthodontic Laboratory

Dental Arts Orthodontic Laboratory is a Anaheim, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Prosthetic Components

American Prosthetic Components is a Green Bay, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Elixir Medical

Elixir Medical Corporation, a privately-funded company based in Milpitas, California, develops next-generation platforms to treat coronary and peripheral artery disease that are designed to restore the adaptive remodeling and pulsatile motion capabilities of the blood vessel. The company`s mission is to transform the care of patients with heart and vascular disease through innovation.

Invendo Medical

Invendo Medical aims to become a globally leading developer and distributor of disposable, highly flexible and easy-to-use endoscopy products in the field of gastroenterology. Innovation activity in gastroenterological endoscopy has in the past decades nearly exclusively focused on the improvement of optical capabilities. However, invendo medical´s goal is to improve patient compliance and thereby increase the number of procedures performed. In order to achieve its goal the company first focussed on an application in the diagnosis and treatment of colorectal cancers (CRC). CRC is the second leading cause of cancer death with an estimated annual worldwide death toll of 510,000 people. More than 1 million new cases are diagnosed every year. However 90-100% of colorectal cancers can be avoided if diagnosed early on

Boston Scientific

At Boston Scientific` we work collaboratively to solve healthcare`s toughest problems by developing solutions that matter most to those suffering from debilitating and life threatening conditions and the healthcare professionals who provide their care. Across 100+ countries` we help providers deliver care more effectively by reducing costs` increasing efficiencies and expanding access to care in order to help more people in more places live longer` healthier lives. We go beyond our mission of transforming patient lives by investing in the future and the well-being of our employees and our planet. Our commitment to sustainability is evident in our Newsweek ranking as the 16th greenest company in the U.S. We also strive to foster a diverse and inclusive work environment and provide opportunities for our 29`000+ employees around the world to serve in their local communities.